Roivant Sciences Ltd. Business Finance Contracts & Agreements

28 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Revenue Interest Purchase and Sale Agreement among Dermavant Sciences GmbH, Dermavant Sciences, Ltd., XYQ Luxco S.À R.L., NovaQuest Co-Investment Fund XVII,...
Modification Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Second Amendment to Funding Agreement among Dermavant Sciences GmbH, Dermavant Sciences Ltd., and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
First Amendment to Credit Agreement among Dermavant Sciences Ltd., Subsidiaries, XYQ Luxco S.à r.l., and U.S. Bank Trust Company
Credit Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2024
Stock Purchase Agreement among Roche Holdings, Inc., Roivant Sciences Ltd., Pfizer Inc., and Telavant Holdings, Inc. dated October 22, 2023
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Common Share Purchase and Sale Agreement between Roivant Sciences Ltd. and Investors (September 2023)
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Restricted Stock Unit Award Grant Notice and Agreement (2021 Equity Incentive Plan)
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Stock Option Grant Notice and Option Agreement (2021 Equity Incentive Plan)
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. 2015 Equity Incentive Plan Performance Option Grant Agreement with Optionholder
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Stock Option Grant Notice under Amended and Restated 2015 Equity Incentive Plan
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Roivant Sciences Ltd. Employee Stock Purchase Plan (as amended March 27, 2023)
Stock Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Description of Roivant Sciences Ltd. Securities Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2023
Investor Rights Agreement among Roivant Sciences Ltd., Pfizer Inc., and Other Investors, Dated November 21, 2022
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2023
Underwriting Agreement for Sale of 26,666,666 Common Shares by Roivant Sciences Ltd. to Underwriters Led by Goldman Sachs & Co. LLC
Underwriting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2023
Underwriting Agreement between Roivant Sciences Ltd., Selling Shareholders, and Cantor Fitzgerald & Co. (November 8, 2022)
Underwriting Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Investor Rights Agreement among Priovant Holdings, Inc., Roivant Sciences Ltd., and Pfizer Inc. dated September 13, 2021
Investor Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amendment No. 1 to Sponsor Support Agreement among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., Patient Square Capital LLC, and Insiders
Modification Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Sponsor Support Agreement among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., and Patient Square Capital LLC (May 1, 2021)
Shareholders Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Subscription Agreement among Montes Archimedes Acquisition Corp., Investor, and Roivant Sciences Ltd.
Subscription Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2022
Third Amended and Restated Registration Rights Agreement among Roivant Sciences Ltd. and Certain Investors
Registration Rights Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2022
Common Shares Purchase Agreement between Roivant Sciences Ltd. and CF Principal Investments LLC (February 14, 2022)
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2022
Amendment No. 2 to Sponsor Support Agreement among Roivant Sciences Ltd., Montes Archimedes Acquisition Corp., and Shareholders
Modification Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Roivant Sciences Ltd. 2021 Equity Incentive Plan
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan (as Amended March 26, 2020)
Equity Distribution Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
First Amendment to Funding Agreement between Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P.
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
DE
2021
Dermavant Sciences GmbH and NovaQuest Co-Investment Fund VIII, L.P. Funding Agreement (July 10, 2018)
Funding Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Amendment Number One to Asset Purchase Agreement between Glaxo Group Limited and Welichem Biotech, Inc.
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
2021
Asset Purchase Agreement between Glaxo Group Limited and Welichem Biotech Inc.
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021
Asset Purchase Agreement by and among GlaxoSmithKline Intellectual Property Development Ltd., Glaxo Group Limited, and Dermavant Sciences GmbH, dated July 10, 2018
Purchase Agreements
Roivant Sciences Ltd.
Pharmaceuticals
NY
2021